EVELYNE M LOYER to Antineoplastic Combined Chemotherapy Protocols
This is a "connection" page, showing publications EVELYNE M LOYER has written about Antineoplastic Combined Chemotherapy Protocols.
Connection Strength
0.262
-
The Addition of Bevacizumab to Oxaliplatin-Based Chemotherapy: Impact Upon Hepatic Sinusoidal Injury and Thrombocytopenia. J Natl Cancer Inst. 2018 08 01; 110(8):888-894.
Score: 0.034
-
Vessel co-option mediates resistance to anti-angiogenic therapy in liver metastases. Nat Med. 2016 11; 22(11):1294-1302.
Score: 0.030
-
RAS mutations predict radiologic and pathologic response in patients treated with chemotherapy before resection of colorectal liver metastases. Ann Surg Oncol. 2015 Mar; 22(3):834-842.
Score: 0.026
-
Paclitaxel, topotecan and rituximab: long term outcomes of an effective salvage programme for relapsed or refractory aggressive B-cell non-Hodgkin lymphoma. Br J Haematol. 2014 Oct; 167(2):177-84.
Score: 0.026
-
Optimal morphologic response to preoperative chemotherapy: an alternate outcome end point before resection of hepatic colorectal metastases. J Clin Oncol. 2012 Dec 20; 30(36):4566-72.
Score: 0.023
-
Is resection of colorectal liver metastases after a second-line chemotherapy regimen justified? Cancer. 2011 Oct 01; 117(19):4484-92.
Score: 0.021
-
Tumor thickness at the tumor-normal interface: a novel pathologic indicator of chemotherapy response in hepatic colorectal metastases. Am J Surg Pathol. 2010 Sep; 34(9):1287-94.
Score: 0.020
-
Optimal modeling for phase I design of a two drug combination-results of a phase I study of cisplatin with 9-nitrocamptothecin. Invest New Drugs. 2008 Dec; 26(6):541-51.
Score: 0.017
-
Portal thrombosis and steatosis after preoperative chemotherapy with FOLFIRI-bevacizumab for colorectal liver metastases. World J Gastroenterol. 2006 Oct 28; 12(40):6556-8.
Score: 0.015
-
Pegfilgrastim administered in a single fixed dose is effective in inducing neutrophil count recovery after paclitaxel and topotecan chemotherapy in patients with relapsed aggressive non-Hodgkin's lymphoma. Leuk Lymphoma. 2006 Mar; 47(3):481-5.
Score: 0.015
-
Phase II study of carboplatin and liposomal doxorubicin in patients with recurrent squamous cell carcinoma of the cervix. Cancer. 2001 Nov 01; 92(9):2327-33.
Score: 0.011
-
Hyperplasia of axillary nodes in patients undergoing immunotherapy. AJR Am J Roentgenol. 1997 Nov; 169(5):1359-62.
Score: 0.008
-
Comparison of early radiological predictors of outcome in patients with colorectal cancer with unresectable hepatic metastases treated with bevacizumab. Gut. 2018 06; 67(6):1095-1102.
Score: 0.008
-
Remission of recurrent cervical cancer with paclitaxel and carboplatin: a case report and review of literature. Eur J Gynaecol Oncol. 1996; 17(6):493-6.
Score: 0.007